NEW YORK, Feb. 10 (GenomeWeb News) - Aventis has licensed two of Ingenuity's pathway analysis products, Ingenuity said today.

Aventis agreed to use Ingenuity Pathways Analysis, a web-delivered application for use by the company's biologists, as well as the Ingenuity Pathways Knowledge Base, a manually curated database of pathway information for use by bioinformaticists creating proprietary in-house analytical solutions.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.